NCT07552181 Trial of Pembrolizumab/Chemotherapy With Live Biotherapeutic Product, MO-03, in Patients With Early Stage Triple Negative Breast Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT07536815 An Open-Label, Multicenter, Non-Randomized Expanded Access Protocol (EAP) Designed to Provide Leronlimab to Patients With Locally Advanced or Metastatic Triple-Negative Breast Cancer (mTNBC) Status AVAILABLE Phase N/A
NCT07491822 A Single-Arm, Single-Center, Phase II Clinical Study of Camrelizumab Combined With Radiochemotherapy as Neoadjuvant Therapy for Early-Stage Triple-Negative Breast Cancer Status NOT_YET_RECRUITING Phase NA
NCT07441512 A Phase II, Single-arm Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Eribulin in Pretreated Advanced Triple-negative Breast Cancer Harboring a PIK3CA Mutation Status NOT_YET_RECRUITING Phase PHASE2
NCT07376629 A Study of HB0025 Plus Nab-paclitaxel as First Line Therapy for TNBC Status ENROLLING_BY_INVITATION Phase PHASE2
NCT07021261 Comparing UTD2 Combined With Capecitabine to Capecitabine as Adjuvant Therapy for Non-pCR TNBC Patients Status NOT_YET_RECRUITING Phase PHASE3
NCT07017673 Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer Status RECRUITING Phase PHASE2
NCT06991790 Sacituzumab Govitecan + Toripalimab as First - Line Therapy for Advanced Triple - Negative Breast Cancer and Biomarker Exploration Status RECRUITING Phase N/A
NCT06769425 HS-10502 Combination Treatment in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06746870 A Phase II Clinical Study to Evaluate the Safety, Pharmacokinetic Profile, and Preliminary Efficacy of IMM2510 in Combination with Chemotherapy As First-line Treatment in Subjects with Non-small Cell Lung Cancer or Triple-negative Breast Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT06682793 A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression Status RECRUITING Phase PHASE1/PHASE2
NCT06210438 SHR-A1921 Combined With Bevacizumab in Triple-negative Breast Cancer With Brain Metastases Status NOT_YET_RECRUITING Phase PHASE2
NCT05918133 A Study of PM8002 Plus Nab-paclitaxel as First Line Therapy for TNBC Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05581004 A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors Status RECRUITING Phase PHASE1
NCT04585750 The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) Status RECRUITING Phase PHASE1/PHASE2